drugset

drugset / Trial / NCT00225524

Study Evaluating Long-Term Safety of Effexor XR in Patients With Major Depression.

NCT00225524 ↗

Phase 3 Completed 150 enrolled Wyeth is now a wholly owned subsidiary of Pfizer

Non-randomizedSingle-groupOpen-labelTreatment

Summary

Phase III long-term safety study of Effexor XR in patients with major depression.

Timeline

Start: 2004-09
Primary completion: —
Completion: —

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Venlafaxine	Small molecule	—	—

Indications